Demand, key results, regional analysis, global sector share, size, share, key player profiles, future prospects and forecasts up to 2024 – Heraldo De La Manga


The Nuclear Medicine Market report provides an overview of the industry including definitions, division, key suppliers, key development and market challenges. The Nuclear Medicine market analysis is provided to markets around the world including key development trends, competitive landscape analysis, market dynamics and key regions development status forecasts 2019-2024

Get a Sample Copy of the Report:

Competitive landscape
The pharmaceutical active ingredients market is very competitive and is made up of several major players; therefore, it indicates a fragmented market scenario. The nuclear medicine market has several manufacturers from China and India who occupy a dominant position in the market, thanks to their large manufacturing presence. In Europe, Italy, Germany and the UK are key regions for the nuclear medicine trade.

Key Vendors of the Nuclear Medicine Market:
– Mallinckrodt
– Lantheus Medical Imaging
– Other group
– Triad of Isotopes
– Siemens Healthcare
– Advanced throttle applications
– curium
– Cambridge Isotope Laboratories Inc.
– Cardinal Health Inc.
– GE Healthcare
– Nordion Inc.
– Taiyo Nippon Sanso Corporation
– Fujifilm Holdings Corporation
– Eczacibasi-Monrol
– Isotec Inc. (Sigma-Aldrich)

Main market trends:

-The application of cardiology is expected to experience strong growth in the market

-The application segment is more subsegmented in cardiology, neurology, oncology and other applications. The main factor driving market growth is the increasing prevalence of cardiovascular disease (CVD) around the world. According to estimates by the World Health Organization (WHO), in 2016, 17.9 million people died from cardiovascular disease.

-The diagnostic segment is further segmented into SPECT and PET. PET imaging radioisotopes have many applications in clinical neurology, including movement disorders, epilepsy, brain tumors, dementia, stroke, and neuronal plasticity. Future applications include early detection of brain metastases, Parkinson’s syndromes, and neurodegenerative disorders, such as Alzheimer’s disease. The radioisotope market is expected to be wider in developing countries due to the growing awareness among people about radioisotopes, the increased incidence of chronic diseases such as cancer and the increase in population.

North America should dominate the nuclear medicine market

North America is the dominant market for nuclear medicine. In North America, the United States is the largest radioisotope consumer market and Canada is the largest producer of Tc-99m. The United States is the largest contributor to the North American region, in terms of revenue, and is expected to maintain its dominance, due to the higher procedural volume and increasing adoption of nuclear medicine for various therapeutic applications.

Asia Pacific is expected to see a healthy CAGR during the forecast period. An increase in demand for nuclear medicines in emerging countries, such as India and China, is due to rising disposable income, improved health standards, and favorable foreign policy reforms.

Ask or share your questions before purchasing this report:

Reasons to buy this report:
– The market estimate sheet (ME) in Excel format
– Customization report based on customer needs.
– 3 months of analyst support

Detailed Summary of the Global Nuclear Medicine Market: Growth, Trends, Forecasts and Challenges
1. Introduction
1.1 Study results
1.2 General assumptions of the study
2. Research methodology
2.1 introduction
2.2 Method of analysis
2.3 Stages of the study
2.4 Econometric modeling
3. Executive summary
4. Market overview and trends in the nuclear medicine market
4.1 introduction
4.2 Market Trends
4.3 Porter’s Five Forces Picture
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining power of consumers
4.3.3 Threat of new entrants
4.3.4 Threat of substitute products and services
4.3.5 Competitive rivalry within the sector
5. Market dynamics of the nuclear medicine market
5.1 Driver
5.1.1 Increase in production
5.1.2 Growing demand
5.2 Restrictions
5.3 Opportunities
6. Segmentation of the world nuclear medicine market by capacity
7. Segmentation of the global nuclear medicine market by type of material
7.1 Type 1
7.2 Type 2
7.3 Type 3
8. Segmentation of the global nuclear medicine market by region
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Rest of North America
8.2 Asia-Pacific
8.2.1 China
8.2.2 Japan
8.2.3 India
8.2.4 Rest of Asia-Pacific
8.3 Europe
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Russia
8.3.5 Rest of Europe
8.4 Rest of the world
8.4.1 Brazil
8.4.2 South Africa
8.4.3 Others
9. Competitive overview and introduction of the nuclear medicine market
9.1 introduction
9.2 Market share analysis
9.3 Key Player Developments
10. Analysis of the main suppliers (overview, products and services, strategies)
10.1 Company 1
10.2 Company 2
10.3 Company 3
11. Disclaimer
And many others??.

Purchase this report (price $ 4,250 for single user license) –

Source link